Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,454,456
  • Shares Outstanding, K 198,173
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,131 M
  • EBIT $ -1,182 M
  • EBITDA $ -1,194 M
  • 60-Month Beta 1.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 17.69

Options Overview Details

View History
  • Implied Volatility 46.48% (+0.98%)
  • Historical Volatility 105.17%
  • IV Percentile 19%
  • IV Rank 9.81%
  • IV High 129.42% on 04/10/26
  • IV Low 37.46% on 09/18/25
  • Expected Move (DTE 25) 11.90 (7.93%)
  • Put/Call Vol Ratio 0.81
  • Today's Volume 4,344
  • Volume Avg (30-Day) 10,769
  • Put/Call OI Ratio 1.38
  • Today's Open Interest 121,824
  • Open Int (30-Day) 124,492
  • Expected Range 138.08 to 161.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-1.83
  • Number of Estimates 10
  • High Estimate $-1.69
  • Low Estimate $-1.92
  • Prior Year $-1.13
  • Growth Rate Est. (year over year) -61.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.52 +63.65%
on 03/30/26
155.70 -3.81%
on 04/16/26
+53.99 (+56.37%)
since 03/20/26
3-Month
91.52 +63.65%
on 03/30/26
155.70 -3.81%
on 04/16/26
+33.55 (+28.87%)
since 01/20/26
52-Week
34.00 +340.51%
on 08/07/25
155.70 -3.81%
on 04/16/26
+113.01 (+307.44%)
since 04/17/25

Most Recent Stories

More News
Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting

REDWOOD CITY, Calif., April 19, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 149.46 (+0.56%)
Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

REDWOOD CITY, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 149.46 (+0.56%)
Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes

REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced...

RVMD : 149.46 (+0.56%)
Stocks Settle Higher in Hopes for an Agreement to End the Iran War

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.02%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.06%. June E-mini S&P...

IDYA : 33.88 (-0.09%)
AVGO : 396.48 (-2.47%)
INTU : 400.54 (+1.85%)
SNDK : 924.06 (+0.33%)
SRE : 93.94 (-0.09%)
$IUXX : 26,553.12 (-0.45%)
ZNM26 : 111-205 (-0.07%)
ESM26 : 7,137.25 (-0.34%)
QCOM : 137.34 (+0.84%)
STX : 539.07 (-1.58%)
BBY : 66.68 (+1.45%)
$DOWI : 49,330.53 (-0.24%)
Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes

REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced...

RVMD : 149.46 (+0.56%)
Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?

Revolution Medicines stock rallies on impressive daraxonrasib Phase 3 results. Here’s why RVMD shares may sustain the momentum moving forward.

MRK : 118.00 (-0.90%)
ABBV : 205.09 (-1.58%)
RVMD : 149.46 (+0.56%)
Stocks Recover as Oracle Leads Software Companies Higher

The S&P 500 Index ($SPX ) (SPY ) today is up +0.09%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.16%. June E-mini S&P futures (ESM26...

ALK : 43.93 (-3.24%)
UAL : 99.04 (-2.71%)
IDYA : 33.88 (-0.09%)
INTU : 400.54 (+1.85%)
SNDK : 924.06 (+0.33%)
$IUXX : 26,553.12 (-0.45%)
ZNM26 : 111-205 (-0.07%)
ESM26 : 7,137.25 (-0.34%)
NCLH : 20.20 (-3.76%)
BBY : 66.68 (+1.45%)
$DOWI : 49,330.53 (-0.24%)
SPY : 708.04 (-0.30%)
Stocks Mixed as US Set to Blockade the Strait of Hormuz

The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.21%. Stock indexes are mixed this...

ALK : 43.93 (-3.24%)
MSTR : 169.29 (+1.66%)
UAL : 99.04 (-2.71%)
IDYA : 33.88 (-0.09%)
CVX : 184.18 (+0.10%)
SNDK : 924.06 (+0.33%)
GLXY : 26.21 (+1.43%)
$IUXX : 26,553.12 (-0.45%)
COIN : 208.47 (+1.04%)
ZNM26 : 111-205 (-0.07%)
OXY : 54.91 (+2.08%)
FANG : 185.05 (+2.65%)
Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

Trial met all primary and key secondary endpoints, including progression-free survival and overall survival Company intends to include these data in a future New Drug Application submission to the...

RVMD : 149.46 (+0.56%)
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer 

REDWOOD CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced...

RVMD : 149.46 (+0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 156.95
2nd Resistance Point 154.04
1st Resistance Point 151.34
Last Price 149.46
1st Support Level 145.72
2nd Support Level 142.81
3rd Support Level 140.11

See More

52-Week High 155.70
Last Price 149.46
Fibonacci 61.8% 109.21
Fibonacci 50% 94.85
Fibonacci 38.2% 80.49
52-Week Low 34.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.